Skip to content

A Phase I study of STA551 and STA551 in combination with atezolizumab in patients with solid tumours

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-508764-30-00
Acronym
STA101JG
Enrollment
30
Registered
2023-12-18
Start date
2024-07-31
Completion date
Unknown
Last updated
2025-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally advanced or metastatic solid tumors

Interventions

None listed

Sponsors

Chugai Pharmaceutical Co. Ltd.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Poland, Romania, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026